“Influence of the immune system on the successful discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia”, Acervo Saúde, vol. 26, no. 1, p. e22317, Jan. 2026, doi: 10.25248/reas.e22317.2026.